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Abstract Q-Aminobutyric acid, a major inhibitory neurotrans-
mitter within the adult central nervous system, is also known to
be excitatory at early developmental stages due to the elevated
intracellular Cl3 concentration. This functional change is pri-
marily attributable to a K+-Cl3 cotransporter, KCC2, the ex-
pression of which is developmentally regulated in neurons. How-
ever, little detail information is available concerning the
intracellular regulation of KCC2 function. Here, we identify
an interaction between KCC2 and brain-type creatine kinase
by means of yeast two-hybrid screening. This interaction, which
was also detected in cultured cells and brain extracts, might
contribute to KCC2-mediated modulation of Cl3 homeostasis.
# 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Q-Aminobutyric acid (GABA) is well known to be a major
inhibitory neurotransmitter within the adult central nervous
system, but recently it has also been found to function as an
excitatory neurotransmitter both during the developmental
stage and during periods of neuronal injury [1^3]. Whether
it is inhibitory or excitatory would seem to be determined
by the intracellular Cl3 concentration ([Cl3]i) [1,4,5]. Thus,
in immature or injured neurons, the relatively high [Cl3]i ren-
ders the Cl3 equilibrium potential (ECl) positive to the resting
membrane potential, so that activation of GABAA receptor
channels results in an outward £ux of Cl3 and a consequent
depolarization of the neuron. In contrast, in mature neurons
ECl is so negative to the resting membrane potential, due to
the low [Cl3]i, that activation of the above channels leads to
an in£ux of Cl3 and a consequent neuronal hyperpolariza-
tion.
Electroneutral transporters for Cl3 play important roles in
determining the resting [Cl3]i, and a neuron-speci¢c Kþ-Cl3
cotransporter, KCC2 [6], is involved in the developmental
regulation of [Cl3]i in neurons [3]. This cotransporter extrudes
Kþ and Cl3 out of the cells, so reducing [Cl3]i, and its ex-
pression is upregulated during development [7^9]. However, it
is downregulated after neuronal injury, resulting in an ele-
vated [Cl3]i [10,11]. Thus, KCC2 is implicated in the devel-
opmentally regulated bidirectional responses to GABA. In
addition, it has been reported that KCC2 is localized at den-
dritic spines [12], and colocalized with either GABA receptors
[13] or gephyrin, which clusterizes GABA and glycine recep-
tors [14], indicating a crucial role in the control of the re-
sponses to GABA and glycine. However, we have as yet few
details about the intracellular regulation of KCC2, except the
inference that some protein kinases modulate its function
[15,16]. This gave us the idea that unidenti¢ed protein(s)
may a¡ect the function of KCC2 by interacting with mole-
cules physically close to KCC2. In this report, we describe a
yeast two-hybrid screening study using the C-terminal cyto-
plasmic region of KCC2 as bait, and isolated brain-type crea-
tine kinase (CKB), an ATP-generating enzyme.
2. Materials and methods
2.1. Plasmid constructs
The cDNAs of CKB, KCC1, and Naþ-Kþ-Cl3 cotransporter 1
(NKCC1) were obtained by means of the polymerase chain reaction
(PCR), using adult rat brain cDNA as a template. The full-length
KCC2 cDNA (kindly provided by Dr. J.A. Payne) was ampli¢ed by
PCR and subcloned into pCMV-Tag2B (Stratagene). PCR products
encoding 645^1116 amino acids (aa), 645^1114 aa, 645^1048 aa, and
645^914 aa of KCC2, 665^1085 aa of KCC1, and 751^1203 aa of
NKCC1 were subcloned into pBTM116 (kindly provided by Dr. M.
Hagiwara). The PCR fragment of CKB was cloned into pcDNA3
(Invitrogen) expressing a hemagglutinin (HA) tag. All clones derived
by PCR were veri¢ed by DNA sequencing.
2.2. Two-hybrid assays
Two-hybrid screening assays were performed as described previ-
ously [17]. Brie£y, for the present purposes yeast strain L40 was co-
transformed with pBTM116-KCC2 (645^1116 aa) and a rat brain
cDNA library constructed in pACTII (Clontech). Positive clones on
synthetic complete plates lacking tryptophan, leucine, and histidine
were further analyzed.
2.3. Cell culture and transfection
COS-7 cells were maintained in Dulbecco’s modi¢ed Eagle’s me-
dium (Invitrogen) supplemented with 10% fetal bovine serum at 37‡C
in an atmosphere containing 5% CO2. Transfection was performed
with the aid of Lipofectamine (Invitrogen) according to the manufac-
turer’s protocol.
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2.4. Coimmunoprecipitation
To provide culture cells, 1U106 cells growing on 10-cm Petri dishes
were transfected with appropriate plasmids for 48 h, then lysed in lysis
bu¡er (50 mM Tris^HCl, pH 7.5, 100 mM NaCl, 1% Triton X-100,
and protease inhibitor). After centrifugation at 12 000 rpm at 4‡C for
30 min, 250 Wg of the supernatants were incubated with 5 Wg of anti-
Flag M2 antibody (Sigma) and protein G (Amersham Pharmacia
Biotech) for 2 h at 4‡C. After washing three times with wash bu¡er
(lysis bu¡er without protease inhibitor), the pellets were mixed with
1ULaemmli sample bu¡er, and boiled. They were then centrifuged,
and the supernatants were analyzed by immunoblotting using anti-
HA (1:1000; MBL) and anti-KCC2 (1:2500; Upstate Biotechnology)
antibodies.
To make brain extracts, rat whole brains were homogenized, then
lysed in lysis bu¡er. The subsequent protocol was as described above
except for the use of anti-KCC2 antibody, rabbit IgG (Sigma), or
anti-NKCC1 monoclonal antibody (T4; Departmental Studies Hy-
bridoma Bank, Iowa City, IA, USA) instead of anti-Flag M2 anti-
body for the immunoprecipitation, and anti-CKB antibody (1:500;
Santa Cruz) instead of anti-HA antibody for the immunoblotting.
2.5. Immunoblotting
Samples were resolved by sodium dodecyl sulfate^polyacrylamide
gel electrophoresis (SDS^PAGE), followed by electrotransfer onto
polyvinylidene di£uoride membranes. For visualization, blots were
probed with appropriate primary antibodies, then detected using
horseradish peroxidase-conjugated secondary antibodies (1:1000;
New England BioLabs) and an ECL kit (Amersham Pharmacia Bio-
tech).
2.6. Immuno£uorescence staining
Transfected cells on coverslips were ¢xed in 4% paraformaldehyde
in phosphate-bu¡ered saline (PBS), followed by permeabilization in
PBS containing 0.2% Triton X-100. The cells were then incubated
with anti-Flag M2 (1:1000) and anti-HA (1:1000) antibodies, fol-
lowed by incubation with £uorescein isothiocyanate-conjugated anti-
rabbit (1:100; Zymed Laboratories) and Texas red-conjugated anti-
mouse (1:100; Molecular Probes) antibodies. For DNA staining, cov-
erslips were incubated with 1 Wg/ml 4P,6-diamidino-2-phenylindole
(DAPI) (Sigma). Fluorescent images were analyzed by a £uorescence
microscopy.
3. Results
3.1. Isolation of a KCC2-interacting protein using yeast
two-hybrid screening
When we screened 1U106 transformants of the rat brain
cDNA library using as bait the C-terminal cytoplasmic region
of KCC2 (645^1116 aa), we obtained 60 positive clones. After
con¢rmation and partial sequencing, 22 clones were found to
encode CKB (Fig. 1A). The common region of overlap shared
by all the CKB spanned 273^381 aa.
To identify the precise region of KCC2 required for the
interaction with CKB, we prepared various truncated con-
structs of the C-terminal cytoplasmic region of KCC2, and
examined the interaction with CKB using the two-hybrid as-
say. CKB interacted with 645^1116 aa and 645^1114 aa, but
not with 645^1048 aa or 645^914 aa, of KCC2 (Fig. 1B),
indicating that the 1049^1114 aa region of KCC2 is required
for the interaction.
3.2. Interaction of KCC1, but not NKCC1, in yeast two-hybrid
assay
Alignments of amino acid sequences showed that the 1049^
1114 aa region of KCC2 is highly homologous to the corre-
sponding regions of KCC1, KCC3, and KCC4, which are the
other members of the Kþ-Cl3 cotransporter family, but not to
that of NKCC1, which is one of the cation-Cl3 cotransporter
superfamily (Fig. 2A). We therefore examined whether CKB
interacts with other Cl3 transporters, such as KCC1 and
NKCC1, the expressions of which have been identi¢ed in
brain [18]. CKB was found to associate with the C-terminal
cytoplasmic region of KCC1, but not with that of NKCC1
(Fig. 2B).
3.3. Interaction of KCC2 with CKB in culture cells
To determine whether CKB associates with KCC2 in vivo,
we performed coimmunoprecipitation assays. COS-7 cells
were transiently transfected with or without plasmids express-
ing full-length HA-CKB and/or full-length Flag-KCC2. After
immunoprecipitation using anti-Flag M2 antibody, HA-CKB
was detected in a cell lysate containing both HA-CKB and
Flag-KCC2 by the use of anti-HA antibody, but not in the
others (Fig. 3A).
Fig. 1. Interaction of CKB with KCC2 in yeast two-hybrid assay.
A: KCC2+ indicates lexA fused to the C-terminal cytoplasmic re-
gion of KCC2 used as bait, while KCC23 indicates lexA alone in
the vector pBTM116. CKB (260^381 aa) was either fused (CKB+)
to the Gal4p activation domain in the vector pACTII, or not fused
(CKB3). The transformants were selected on Trp3 Leu3 plates
(His+), and the interactants were subsequently selected on Trp3
Leu3 His3 plate (His3). B: Schematic diagram showing the re-
sults, from the yeast two-hybrid assay, concerning the interaction
between CKB and various deletion constructs of KCC2. Numbers
refer to amino acid positions in rat KCC2.
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3.4. Subcellular distributions of KCC2 and CKB in culture cells
Next, we examined whether KCC2 colocalized with CKB in
transfected COS-7 cells. Immuno£uorescence analysis showed
that CKB was distributed mainly throughout the cytoplasm.
KCC2 was located mostly in the perinuclear region, but also
in the cytoplasm (Fig. 3B). These observations suggest that
KCC2 and CKB colocalized to some extent. Essentially, the
same experiment was then performed using HEK293 cells,
and similar results were obtained (data not shown).
3.5. Interaction of KCC2 with CKB in brain extract
To explore whether KCC2 and CKB can associate under
physiological conditions, we carried out immunoprecipitations
using rat brain extracts. Immunoprecipitation by anti-KCC2
antibody resulted in a coprecipitation of CKB in the brain
extract, whereas CKB was not coprecipitated with a control
rabbit IgG or anti-NKCC1 antibody (Fig. 4). This result in-
dicates that endogenous KCC2 and CKB associate with each
other.
4. Discussion
Here, we used yeast two-hybrid screening to identify CKB
as a binding partner of KCC2, one of the Kþ-Cl3 cotrans-
porters belonging to the electroneutral cation-Cl3 cotrans-
porter superfamily. Our deletion analysis showed that 1048^
1114 aa of KCC2 and 273^381 aa of CKB are important for
the interaction. Furthermore, KCC2 and CKB were found to
interact in transfected COS-7 cells and in adult rat brain,
suggesting that CKB truly is a partner of KCC2 in vivo.
In higher vertebrates, four creatine kinase (CK) isoenzymes
are present: namely, brain (CKB), muscle (CKM), and two
mitochondrial CKs [19]. CKB and CKM are functionally ac-
tive as dimers in three isozymic forms: BB (the predominant
Fig. 2. Interaction of CKB with various Cl3 transporters in yeast two-hybrid assay. A: C-terminal amino acid sequences for representative rat
(KCC2, KCC1, and NKCC1) or human (KCC3 and KCC4) Cl3 transporters. Identical amino acid residues are highlighted by boxes. B: The
C-terminal cytoplasmic region of the indicated transporter was either fused to the Gal4p activation domain in the vector pACTII, or not fused
(3). The transformants with lexA-fused CKB (260^381 aa) were selected as described in Fig. 1A.
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form in brain), MM (in skeletal muscle) and MB (in cardiac
muscle). CKs regenerate ATP by catalyzing the exchange of
high-energy phosphates between Q-ATP and phosphocrea-
tine (PCr) according to: MgATP23+creatineHMgADP3+
PCr23+Hþ [19]. CKB, which is expressed in a number of
tissues, is especially abundant in brain [20], in which most
CKB has been shown to be cytosolic, although a number of
reactions requiring CKB are membrane-associated. Indeed,
CKB has been found to bind to a membrane-associated
thrombin receptor, PAR-1, leading to functional activation
[21]. In addition, CKs have been reported to interact physi-
cally with the ATP-sensitive Kþ channel [22] and to localize to
acetylcholine receptor-rich membranes [23]. Thus, membrane-
associated CKs are considered to play an important role in
regenerating the ATP necessary for the ion-driving force,
although the question as to the precise identity of the targets
has not been fully addressed.
In neuronal cells, CKB is located in synaptic regions [24], in
which KCC2 is also localized [14]. Moreover, Naþ-Kþ ATP-
ase preferentially localizes to dendrites [25] and is considered
to be functionally coupled either with KCC2 or, independent-
ly, with CKB [3,26]. From this point of view, the notion of an
interaction between KCC2 and CKB would seem to be reli-
able. Since CKB also seems to be associated with the ubiqui-
tously expressed KCC1, we employed the two-hybrid assay to
examine the interactions between CKM and KCCs in the
hope of revealing whether interactions between KCCs and
CKs are common phenomena. However, we could not detect
any interaction between KCCs and CKM (data not shown).
The functional signi¢cance of the interaction between
KCC2 and CKB is not clear, and how the intracellular ATP
level might contribute to KCC2 function is still a matter for
discussion. Since an ATP is necessary for activation of Naþ-
Kþ ATPase, leading to a driving force for KCC, ATP should
enhance the function of KCC2. Indeed, some reports have
a⁄rmed an ATP-induced KCC activation [27,28], although
contrariwise a decrease in the ATP level has also been re-
ported to activate KCC [29]. In another possible scheme,
CKB may provide ATP to other molecules, such as kinases,
that are physically close to KCC2, so helping to maintain
membrane Cl3 homeostasis. Indeed, a broad-spectrum pro-
tein kinase inhibitor, staurosporine, stimulates KCC activity
Fig. 3. Coimmunoprecipitation and colocalization of CKB with
KCC2. A: HA-CKB was transiently transfected into COS-7 cells
with or without Flag-KCC2. The cells were lysed, and then immu-
noprecipitation was performed using anti-Flag monoclonal antibody.
The lysates and immunoprecipitates were analyzed by SDS^PAGE
and immunoblotted using anti-KCC2 and anti-HA polyclonal anti-
bodies. B: COS-7 cells were transiently transfected with expression
plasmids for HA-CKB and Flag-KCC2, and an immuno£uorescence
analysis was performed using anti-HA polyclonal (top) or anti-Flag
monoclonal (middle) antibodies. For DNA staining, the cells were
incubated with DAPI (bottom).
Fig. 4. Interaction of CKB with KCC2 in rat brain extracts. Solubi-
lized extracts from adult rat brain were subjected to immunoprecipi-
tation analysis using rabbit IgG, anti-KCC2 antibody, or anti-
NKCC1 antibody. Extracts (5 Wg) and immunoprecipitates were an-
alyzed by SDS^PAGE and immunoblotted using anti-CKB poly-
clonal antibodies. Precipitation of KCC2 or NKCC1 was detected
using anti-KCC2 or anti-NKCC1 antibody, respectively (data not
shown).
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while protein tyrosine kinases enhance KCC2 functional ac-
tivity [16,30]. In this concern, aside from the provision of
ATP, CKB might phosphorylate KCC2 to change its func-
tion, because CKB possesses autophosphorylation activity
[31]. Although these issues require further detailed explora-
tion, the ¢ndings in this report do at least provide an insight
into the relationship between KCCs and ATP.
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